MyFinsight
Home
About
Contact
fdmt: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, FDMT has $423,982K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
423,982
473,637
Total stockholders equity
368,983
420,890
Total liabilities and stockholders equity
423,982
473,637
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Total property and
equipment
$36,216K
Prepaid expenses and
other current assets
$7,314K
Marketable securities
$256,508K
Cash and cash
equivalents
$48,555K
Other assets
$9,380K
Operating lease
right-of-use assets, net
$18,907K
Property and equipment,
net
$16,153K
Marketable securities,
long-term
$67,165K
Total current assets
$312,377K
Less accumulated
depreciation and...
$20,063K
Total assets
$423,982K
Total liabilities and
stockholders equity
$423,982K
Total stockholders
equity
$368,983K
Total liabilities
$54,999K
Accumulated deficit
-$735,701K
Accumulated other
comprehensive gain
$671K
Additional
paid-in-capital
$1,104,008K
Other liabilities
$144K
Operating lease
liabilities, long-term...
$16,568K
Derivative liability
$345K
Deferred revenue, net of
current portion
$835K
Total current
liabilities
$37,107K
Common stock, 0.0001
par value,...
$5K
Operating lease
liabilities, current portion
$5,695K
Deferred revenue
$360K
Accrued and other
current liabilities
$24,189K
Accounts payable
$6,863K
Buy me a coffee
4D Molecular Therapeutics, Inc. (FDMT)
4D Molecular Therapeutics, Inc. (FDMT)